Valuation: Cenra Inc.

Market Cap 5.36B 168M 144M 134M 123M 231M 16.07B 236M 1.59B 620M 8.05B 630M 617M 26.66B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.62B 239M 204M 191M 175M 329M 22.83B 335M 2.26B 881M 11.44B 896M 876M 37.87B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
60.95%
Yield 2024
2.72%
Yield 2025 3.01%
1 day+4.04%
1 week+2.27%
Current month+9.91%
1 month+5.56%
3 months+5.26%
6 months+6.34%
Current year+7.93%
1 week 33.8
Extreme 33.8
37.65
1 month 31.85
Extreme 31.85
37.65
Current year 31.55
Extreme 31.55
37.65
1 year 31.55
Extreme 31.55
37.65
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 05/11/2020
Director of Finance/CFO - 07/03/2014
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 27/05/2016
Chairman - 05/11/2020
Director/Board Member - 17/01/2020
Change 5-day change 1-year change 3-year change Capi.($)
+4.04%+2.27%+7.13% - 165M
-0.08%-1.43%+15.99%+67.26% 47.74B
-3.21%+1.37%+52.36%+125.75% 41.7B
-0.40%-1.23%-10.08%+16.08% 12.14B
+1.11%-1.34%+13.61%+71.49% 11.55B
0.00%0.00%+30.00%+147.62% 9.18B
-0.39%+0.62%+19.93%+39.54% 7.54B
-1.35%+0.74%+47.03%-11.93% 7.35B
-0.64%-0.02%+19.42%+199.06% 6.88B
+2.65%-3.55%-31.27%+24.03% 5.72B
Average +0.17%-0.21%+16.41%+75.43% 15B
Weighted average by Cap. -0.87%-0.54%+24.73%+83.77%

Financials

2024 2025
Net sales 8.92B 279M 239M 223M 205M 385M 26.72B 392M 2.65B 1.03B 13.39B 1.05B 1.03B 44.33B 8.57B 268M 230M 214M 197M 370M 25.67B 377M 2.54B 991M 12.87B 1.01B 986M 42.6B
Net income 317M 9.94M 8.51M 7.94M 7.28M 13.68M 951M 13.95M 94.16M 36.7M 476M 37.31M 36.49M 1.58B 300M 9.39M 8.04M 7.5M 6.89M 12.94M 899M 13.19M 89.03M 34.71M 450M 35.27M 34.51M 1.49B
Net Debt 2.46B 76.93M 65.87M 61.45M 56.39M 106M 7.36B 108M 729M 284M 3.69B 289M 283M 12.21B 2.26B 70.65M 60.49M 56.44M 51.79M 97.31M 6.76B 99.23M 670M 261M 3.39B 265M 260M 11.22B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
20/08/26 NT$36.05 +4.04% 1,465,567
19/08/26 NT$34.65 +1.91% 374,144
18/08/26 NT$34.00 -2.16% 777,542
17/08/26 NT$34.75 -0.14% 588,447
14/08/26 NT$34.80 -1.28% 232,954
  1. Stock Market
  2. Stocks
  3. 3716 Stock